Tiotropium (Spiriva) Rehabilitation Study

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

February 28, 2003

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium

Trial Locations (19)

Unknown

University of Alabama at Birmingham, Birmingham

Boehringer Ingelheim Investigational Site, Phoenix

Attention: John E. Hodgkin, M.D., Deer Park

Boehringer Ingelheim Investigational Site, Long Beach

UCLA School of Medicine, Los Angeles

Boehringer Ingelheim Investigational Site, San Diego

Harbor-UCLA Research and Education Institute, Torrance

Boehringer Ingelheim Investigational Site, Fort Collins

Boehringer Ingelheim Investigational Site, Wheat Ridge

Boehringer Ingelheim Investigational Site, Danbury

St. Francis Hospital and Medical Center, Hartford

Norwalk Hospital, Norwalk

Boehringer Ingelheim Investigational Site, Elk Grove Village

UMass Memorial Medical Center, North Worcester

Henry Ford Hospital, Detroit

University of Nebraska Medical Center, Omaha

Duke University Medical Center, Durhan

Temple University Hospital, Philadelphia

Boehringer Ingelheim Investigational Site, Everett

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY